|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
Thursday, July 17
Liquinimod: Phase III Trial of Oral Drug by Teva
by
All About MS
on Thu 17 Jul 2008 08:50 AM CST
- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech AB (OMX NORDIC: ACTI) announced today that patients are being enrolled for the BRAVO Phase III pivotal trial. BRAVO is a global, 24-month, double-blind study designed to evaluate the efficacy, safety and tolerability of the oral compound more »
|
|||||||||||||||||||||||||||||||||||||||||||||||
